Bobby Helmedag

Bobby Helmedag is the Director at Emergo Therapeutics. Bobby has over fifteen years of experience in the corporate finance and strategic planning industries. Prior to joining Emergo, Bobby served as the Corporate Finance & Strategic Planning Manager at UNC REX Healthcare. Bobby also worked as the Corporate Development Manager at BlueCross BlueShield of Tennessee and as an Analyst at Tomlin & Company. Bobby began their career as an Associate at KPMG. Bobby holds a Bachelor of Science in Accounting from the University of Tennessee and a Master of Business Administration from Vanderbilt University.

Bobby Helmedag has a BBA from the University of Notre Dame and an IMBA from the Darla Moore School of Business. Bobby is currently enrolled in the Manchester Business School.